Skip to content
Search

Latest Stories

Excess weight almost doubles risk of womb cancer, researchers from University of Bristol find

New research shows that lifelong excess weight almost doubles a woman's risk of developing womb cancer.

The findings of the study were published in 'BMC Medicine'. The study from the University of Bristol is one of the first to find that for every fiver extra BMI units, a woman's risk of womb (endometrial) cancer is almost doubled (an increase of 88 per cent).


This is higher than most previous studies have suggested and reflects lifelong weight status rather than a snapshot in time like most other studies.

Five BMI units is the difference between the overweight category and the obese category, or of a 5'5 adult woman being two stones heavier.

The international study looked at genetic samples from around 120,000 women from Australia, Belgium, Germany, Poland, Sweden, the UK, and the USA of which around 13,000 had womb cancer. This large statistical analysis is one of the first studies of its kind to look at the effect of lifelong greater BMI on womb cancer risk.

The researchers looked at markers of 14 traits, which could link obesity and womb cancer. They uncovered two hormones -- fasting insulin and testosterone -- which increased the risk of being diagnosed with womb cancer.

By pinpointing exactly how obesity increases the risk of cancer, such as through hormones, scientists in the future could use drugs to reduce or increase the level of these hormones in people already at a higher risk of cancer.

For example, drugs like metformin used in diabetes treatment can reduce the levels of hormones and research suggests this drug also affects cancer risk, though further study is ongoing.

Womb cancer is one of the cancer types most closely linked with obesity. It's the most common gynaecological cancer in high-income countries and is the fourth most common cancer for women in the UK -- one in 36 women will be diagnosed in their lifetime. And of UK womb cancer cases, it's estimated that around a third are caused by being overweight and obese.

Being overweight or obese is the second-highest preventable cause of cancer in the UK. It's estimated that more than one in 20 cancer cases in the UK are caused by excess weight.

Emma Hazelwood, lead author of the paper said, "This study is an interesting first step into how genetic analyses could be used to uncover exactly how obesity causes cancer, and what can be done to tackle it. Links between obesity and womb cancer are well-known but this is one of the largest studies which has looked into exactly why that is on a molecular level. We look forward to furthering research exploring how we can now use this information to help reduce the risk of cancer in people struggling with obesity."

Dr Julie Sharp, head of health information at Cancer Research UK said, "Cancer Research UK has been leading the way in uncovering links between obesity and cancer for years. Studies like this bolster the fact that being overweight or obese is the second biggest cause of cancer in the UK and can help us start to pinpoint why. This will play a pivotal role in uncovering how to prevent and treat cancer in the future."

"More research is needed to investigate exactly which treatments and drugs could be used to manage cancer risk among people struggling with obesity. We already know that being overweight or obese increases your risk of developing 13 different types of cancer. To reduce your cancer risk, it's important to maintain a healthy weight by eating a balanced diet and staying active," Sharp added.

When Kath first started experiencing bleeding in 2013, she put it down to menopause. Despite urges from her daughter to get checked out, she carried on doing the job she loved -- working as a bra fitter in Debenhams Trafford. But just before Christmas in 2013, she had a heavy bleed which prompted her to make an appointment with the doctor.

In January 2014, Kath went to her GP and was referred to Royal Bolton Hospital where she had a biopsy. She was diagnosed with womb cancer.

"When you hear the word cancer your mind runs riot and I was thinking: 'Am I going to live to see my grandchildren grow up?'" Kath said.

"I felt sick as I didn't know what was going on. It was as though I was in a dream. I was devastated when I found out and cried with my husband holding my hand."

Thankfully, Kath's cancer was caught at the earliest possible stage, which meant she could have life-saving surgery which removed her ovaries and cervix. The operation removed all cancer, which meant she didn't need radiotherapy or chemotherapy, and she is now cancer-free.

But her journey did not end there. "After finishing my treatment I wanted to make some changes," Kath said.

"We don't know what caused my cancer, but I have to admit that I was carrying a few extra pounds. So now I exercise and eat better to be healthier. I also wanted to be a role model for my family."

Kath takes part in CRUK's Race For Life every year, raising both money and awareness about cancer.

"Reading some of the words on people's backs about why they were running brought it all back to me about how important this is," Kath said.

"My daughter's notes said: 'Running for our Mum who beat womb cancer!'"

"It's worrying to see that womb cancer rates are on the rise, and although weight isn't the only risk factor, I want to encourage other women to live healthily so that fewer women go through what I went through.

"I hope that my story helps others make a change in their life," Kath concluded.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Cat Smith MP Leads Call for Urgent Action

Health minister Wes Streeting

Pic credit: Getty Images

Urgent review into medicine shortages needed, ministers tell Streeting

Health minister Wes Streeting has been urged by 45 MPs to call an urgent review into medicine shortages that is impacting the health and safety of patients.

The news comes on the back of the death David Compton, a 44-year-old man who fell and suffered a heart attack which has been linked to him not being able to get medication for epilepsy.

Keep ReadingShow less